Pharvaris N.V. (PHVS)
PHVS
Loading signal…
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.1B
- Beta
- -2.46
- P/E (TTM)
- -9.92
- Short % float
- 6.05%
- Days to cover
- 2.8
- SI change
- +12.5%
- 1W
- -3.53%
- 1M
- -22.75%
- vs SPY 1W
- -3.40%
- vs SPY 1M
- -25.25%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FAQ
- What is LOPJLB’s current signal on PHVS?
- LOPJLB publishes daily direction and regime signals for PHVS on this page.
- What market regime is PHVS in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does Pharvaris N.V. (PHVS) do?
- Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and…